Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Epigral is scheduled to hold a one-on-one meeting with Systematix Group on May 8, 2026, via video conferencing. The company confirmed that no unpublished price sensitive information will be discussed.
May 06 2026 18:05:00
Epigral Limited
Epigral Ltd submitted the transcript of its Q4 FY26 earnings conference call. The call discussed the company's record Q4 revenue of Rs.736 crore, strong EBITDA and PAT growth, and an optimistic outlook for FY27 volume growth and ongoing capex projects.
May 06 2026 13:05:00
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Epigral announced the availability of the audio recording for its conference call held on May 2, 2026. This call discussed the Q4 FY2026 financial results, providing investors access to detailed discussions.
May 03 2026 20:05:00
Epigral Limited
Epigral Limited's Board has recommended a final dividend of Rs. 5 per equity share for the financial year 2025-26. The record date and book closure details will be announced in due course.
May 02 2026 16:05:00
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Epigral reported a record revenue of Rs 736 crore for Q4 FY26, marking a 17% YoY growth. Net profit for the quarter rose 109% sequentially to Rs 82 crore. The company also proposed a final dividend of Rs 5 per equity share for FY2026 and spent Rs 394 crore on capex in FY2026.
May 02 2026 16:05:00
Epigral Ltd - 543332 - Board Meeting Outcome for Approved Audited Financial Results (Standalone & Consolidated) For The Fourth Quarter And
Year Ended On 31St March, 2026 And Recommended Final Dividend Of Rs. 5.00 (50%) Per Equity Share
Epigral's board approved Q4 FY26 cons. financial results, with revenue at ₹736.16 crore and net profit at ₹80.95 crore. The company also recommended a final dividend of ₹5.00 per equity share for FY26, to be paid as per the provisions of the Companies Act.
May 02 2026 15:05:00
Epigral Limited
Epigral's board will meet on May 2, 2026, to consider audited standalone and cons. financial results for FY26. They will also consider a final dividend for shareholders.
Apr 27 2026 12:04:00
Epigral Limited
Epigral Limited's board will convene on May 2, 2026, to consider and approve the audited financial results for the fourth quarter and full financial year ending March 31, 2026. The agenda also includes a potential recommendation for a final dividend.
Apr 27 2026 12:04:00
Epigral Limited
Epigral Limited initiated a postal ballot for the re-appointment of three Non-Executive Independent Directors. Mr. Sanjay Asher, Mr. Kanubhai Patel, and Mr. Raju Swamy are proposed for a second five-year term each, effective May 20, 2026, with voting ending May 19, 2026.
Apr 17 2026 12:04:00
Epigral Limited
Epigral is seeking shareholder approval through postal ballot for the re-appointment of three Non-Executive Independent Directors for a second five-year term. The e-voting period is scheduled from April 20, 2026, to May 19, 2026, with results by May 21, 2026.
Apr 17 2026 12:04:00
Read More